Despite recent hospice and home-based care acquisitions involving health systems, such transactions are unlikely to become a common practice during 2021 and 2022. However, health systems are taking a closer look at companies that provide non-medical assistance to help seniors age in place.
Rising interest from special-purpose acquisition companies (SPACs) could make competition in an already active hospice M&A market more fierce in coming years.
Private equity interest in the hospice sector has been gaining momentum in recent years, raising the stakes in hospice deals and stepping up competition for acquisition targets.
Over the last few months, Addus HomeCare Corporation (Nasdaq: ADUS) has had to deal with a challenging legislative environment and significant COVID-19 surges that have affected clients and caregivers alike.
Find out what Mark A. Kulik, MAMI, Managing Director at BRAFF, told Home Health Care News regarding trends and themes in health care services.
Mergers and acquisitions activity keeps increasing for hospice businesses due to the availability of capital and demographic growth.
Smaller agencies are more likely to take a financial hit next year after CMS finalized its proposal that will phase out Requests for Anticipated Payments.
One of the most consistent trends in home health and hospice mergers and acquisitions is that when one is up, the other is down.
Following this year’s annual National Association for Home Care & Hospice Conference, the scariest event facing the Home Health industry wasn’t Halloween...it was the pending implementation of Patient-Driven Groupings Model (PDGM) beginning January 1, 2020!
The hospice mergers & acquisition market has been at an all-time high for the past 18-24 months, but some sellers seem to enjoy a higher valuation than others. Why? There are many reasons, beyond just size, why some agencies are worth more in the eyes of a buyer.